Severe COVID-19 infection in a child receiving immunotherapy for cancer.
作者信息
Smith Valeria R, Whittle Sarah B, Coleman Ryan D, Munoz Flor M, De Guzman Marietta M, Foster Jennifer H, Navai Shoba A
机构信息
Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Section of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
出版信息
Pediatr Blood Cancer. 2021 Mar;68(3):e28710. doi: 10.1002/pbc.28710. Epub 2020 Sep 15.
Abstract
摘要
相似文献
1
Severe COVID-19 infection in a child receiving immunotherapy for cancer.一名正在接受癌症免疫治疗的儿童感染了重症新冠病毒。
Pediatr Blood Cancer. 2021 Mar;68(3):e28710. doi: 10.1002/pbc.28710. Epub 2020 Sep 15.
2
Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19.粒细胞-巨噬细胞集落刺激因子：脓毒症和新型冠状病毒肺炎的一个免疫靶点
Cell Mol Immunol. 2021 Aug;18(8):2057-2058. doi: 10.1038/s41423-021-00719-3. Epub 2021 Jul 19.
3
Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia.抗淋巴细胞球蛋白治疗再生障碍性贫血后使用重组人粒细胞巨噬细胞集落刺激因子的随机安慰剂对照研究。
Bone Marrow Transplant. 1991;7 Suppl 2:78-80.
4
Welcome to the 13th Volume of .欢迎来到第13卷。 （你提供的原文不完整，缺少具体书名等信息，我按照字面意思翻译了前面部分）
Immunotherapy. 2021 Jan;13(1):1-3. doi: 10.2217/imt-2020-0308. Epub 2020 Dec 7.
5
Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.卡介苗、干扰素、白细胞介素-2和粒细胞巨噬细胞集落刺激因子四联免疫疗法作为非肌层浸润性膀胱癌的挽救治疗
Urol Oncol. 2017 Dec;35(12):670.e7-670.e14. doi: 10.1016/j.urolonc.2017.07.024. Epub 2017 Aug 8.
6
Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.粒细胞巨噬细胞集落刺激因子在造血系统疾病中的应用：反应的生物学特性与本质
Semin Hematol. 1992 Oct;29(4 Suppl 3):4-13.
7
Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells.采用白消安/美法仑、自体造血细胞移植、抗 GD2 抗体、粒细胞-巨噬细胞集落刺激因子、白细胞介素-2 和单倍体自然杀伤细胞对高危神经母细胞瘤新诊断的儿科患者进行巩固治疗。
Biol Blood Marrow Transplant. 2017 Nov;23(11):1910-1917. doi: 10.1016/j.bbmt.2017.07.011. Epub 2017 Jul 18.
8
Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial.人源化 3F8 抗 GD2 单克隆抗体联合粒细胞-巨噬细胞集落刺激因子治疗抵抗性神经母细胞瘤患者：一项 I 期临床试验。
JAMA Oncol. 2018 Dec 1;4(12):1729-1735. doi: 10.1001/jamaoncol.2018.4005.
9
Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子增强抗GD2单克隆抗体220-51对人神经母细胞瘤的体内外抗肿瘤活性
Int J Mol Med. 1998 Oct;2(4):471-5. doi: 10.3892/ijmm.2.4.471.
10
Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.采用白细胞介素-2和粒细胞巨噬细胞集落刺激因子对转移性黑色素瘤进行维持生物治疗可提高对诱导同步生物化疗有反应的患者的生存率。
Clin Cancer Res. 2002 Sep;8(9):2775-81.
引用本文的文献
1
The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review.新冠病毒病对儿童癌症治疗结果及医疗服务提供的全球影响——一项系统综述
Front Oncol. 2022 Apr 7;12:869752. doi: 10.3389/fonc.2022.869752. eCollection 2022.
2
COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients.儿童和青少年中的COVID-19：免疫功能正常和肿瘤血液学患者的特征及特异性
Mediterr J Hematol Infect Dis. 2022 Jan 1;14(1):e2022009. doi: 10.4084/MJHID.2022.009. eCollection 2022.
3
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).COVID-19 与儿童和青少年急性淋巴细胞白血病：法国儿童癌症和白血病防治协会白血病委员会的更新建议（第 2 版）。
Bull Cancer. 2021 May;108(5):490-500. doi: 10.1016/j.bulcan.2021.02.004. Epub 2021 Mar 11.
4
Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.儿童癌症与 COVID-19 患者的临床表现和结局：一项系统综述。
Pediatr Blood Cancer. 2021 Jun;68(6):e29005. doi: 10.1002/pbc.29005. Epub 2021 Mar 15.
本文引用的文献
1
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches.GM-CSF 疗法治疗 COVID-19：调和对立的治疗方法。
Nat Rev Immunol. 2020 Aug;20(8):507-514. doi: 10.1038/s41577-020-0357-7. Epub 2020 Jun 23.
2
COVID-19 in Children With Cancer in New York City.纽约市癌症儿童中的 COVID-19 。
JAMA Oncol. 2020 Sep 1;6(9):1459-1460. doi: 10.1001/jamaoncol.2020.2028.
3
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation.GM-CSF：从生长因子到组织炎症的中枢介质。
Immunity. 2016 Nov 15;45(5):963-973. doi: 10.1016/j.immuni.2016.10.026.
4
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.Anti-GD2 抗体联合 GM-CSF、白细胞介素-2 和异维 A 酸治疗神经母细胞瘤。
N Engl J Med. 2010 Sep 30;363(14):1324-34. doi: 10.1056/NEJMoa0911123.
Zotero 插件